These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19665448

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.
    Mitsiades CS, Mitsiades N.
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):487-99. PubMed ID: 16001956
    [Abstract] [Full Text] [Related]

  • 23. IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-).
    Rosengren L, Vasilcanu D, Vasilcanu R, Fickenscher S, Sehat B, Natalishvili N, Naughton S, Yin S, Girnita A, Girnita L, Axelson M, Larsson O.
    Biochem Biophys Res Commun; 2006 Sep 08; 347(4):1059-66. PubMed ID: 16857168
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. IGF-I and insulin activate mitogen-activated protein kinase via the type 1 IGF receptor in mouse embryonic stem cells.
    Nguyen TT, Sheppard AM, Kaye PL, Noakes PG.
    Reproduction; 2007 Jul 08; 134(1):41-9. PubMed ID: 17641087
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes.
    Dent P, Han SI, Mitchell C, Studer E, Yacoub A, Grandis J, Grant S, Krystal GW, Hylemon PB.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1685-96. PubMed ID: 16207485
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.
    Wittman M, Carboni J, Attar R, Balasubramanian B, Balimane P, Brassil P, Beaulieu F, Chang C, Clarke W, Dell J, Eummer J, Frennesson D, Gottardis M, Greer A, Hansel S, Hurlburt W, Jacobson B, Krishnananthan S, Lee FY, Li A, Lin TA, Liu P, Ouellet C, Sang X, Saulnier MG, Stoffan K, Sun Y, Velaparthi U, Wong H, Yang Z, Zimmermann K, Zoeckler M, Vyas D.
    J Med Chem; 2005 Sep 08; 48(18):5639-43. PubMed ID: 16134929
    [Abstract] [Full Text] [Related]

  • 31. Inhibitors of insulin-like growth factor-1 receptor tyrosine kinase are preferentially cytotoxic to nutrient-deprived pancreatic cancer cells.
    Momose I, Kunimoto S, Osono M, Ikeda D.
    Biochem Biophys Res Commun; 2009 Feb 27; 380(1):171-6. PubMed ID: 19166817
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
    Velaparthi U, Wittman M, Liu P, Stoffan K, Zimmermann K, Sang X, Carboni J, Li A, Attar R, Gottardis M, Greer A, Chang CY, Jacobsen BL, Sack JS, Sun Y, Langley DR, Balasubramanian B, Vyas D.
    Bioorg Med Chem Lett; 2007 Apr 15; 17(8):2317-21. PubMed ID: 17317169
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The IGF receptor as anticancer treatment target.
    Macaulay VM.
    Novartis Found Symp; 2004 Apr 15; 262():235-43; discussion 243-6, 265-8. PubMed ID: 15562833
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitors.
    Krug M, Erlenkamp G, Sippl W, Schächtele C, Totzke F, Hilgeroth A.
    Bioorg Med Chem Lett; 2010 Dec 01; 20(23):6915-9. PubMed ID: 21035334
    [Abstract] [Full Text] [Related]

  • 40. IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children.
    Iñiguez G, Ormazabal P, López T, Maldonado D, Avila A, Román R, Cassorla F.
    Growth Horm IGF Res; 2009 Jun 01; 19(3):256-61. PubMed ID: 19217812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.